Downregulation of KCNQ4 by Janus kinase 2

Journal of Membrane Biology

Volumn 246, Issue 4, 2013, Pages 335-341

  Hosseinzadeh, Zohreh ^a   Sopjani, Mentor ^a   Pakladok, Tatsiana ^a   Bhavsar, Shefalee K ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cell volume regulation; Erythropoietin; JAK2; K+ channel; Leptin

Indexed keywords

BREFELDIN A; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; POTASSIUM CHANNEL KCNQ4;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL MEMBRANE CONDUCTANCE; CELL VOLUME; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; NONHUMAN; OOCYTE; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; VOLTAGE CLAMP; XENOPUS;

ANIMALS; BREFELDIN A; CELL SIZE; ERYTHROPOIETIN; FEMALE; JANUS KINASE 2; KCNQ POTASSIUM CHANNELS; OOCYTES; TYRPHOSTINS; XENOPUS;

EID: 84876420514     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-013-9537-8     Document Type: Article

References (47)

1. Banes-Berceli AK, Al Azawi H, Proctor D et al (2011) Angiotensin II utilizes Janus kinase 2 in hypertension, but not in the physiologic control of blood pressure, during low salt intake. Am J Physiol Regul Integr Comp Physiol 301:R1169-R1176
2. Baskin R, Majumder A, Sayeski PP (2010) The recent medicinal chemistry development of Jak2 tyrosine kinase small molecule inhibitors. Curr Med Chem 17:4551-4558
3. Bhavsar SK, Hosseinzadeh Z, Merches K et al (2011) Stimulation of the amino acid transporter SLC6A19 by JAK2. Biochem Biophys Res Commun 414:456-461
4. Bohmer C, Sopjani M, Klaus F et al (2010) The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19. Cell Physiol Biochem 25:723-732
5. Brooks AJ, Waters MJ (2010) The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol 6:515-525
6. Dermaku-Sopjani M, Sopjani M, Saxena A et al (2011) Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell Physiol Biochem 28:251-258
7. Eckey K, Strutz-Seebohm N, Katz G et al (2010) Modulation of human ether a gogo related channels by CASQ2 contributes to etiology of catecholaminergic polymorphic ventricular tachycardia (CPVT). Cell Physiol Biochem 26:503-512
8. Feng J, Witthuhn BA, Matsuda T et al (1997) Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol Cell Biol 17:2497-2501
9. + exchange through Janus kinase 2 and calmodulin. J Biol Chem 278:16908-16915
10. Gatsios P, Terstegen L, Schliess F et al (1998) Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock. J Biol Chem 273:22962-22968
11. + channel activity. J Physiol 587:2225-2231
12. + channels tune mechanoreceptors for normal touch sensation in mouse and man. Nat Neurosci 15:138-145
13. Henrion U, Renhorn J, Borjesson SI et al (2012) Tracking a complete voltage-sensor cycle with metal-ion bridges. Proc Natl Acad Sci USA 109:8552-8557
14. Ho K, Valdez F, Garcia R et al (2010) JAK2 Translocations in hematological malignancies: review of the literature. J Assoc Genet Technol 36:107-109
15. Hosseinzadeh Z, Bhavsar SK, Shojaiefard M et al (2011a) Stimulation of the glucose carrier SGLT1 by JAK2. Biochem Biophys Res Commun 408:208-213
16. Hosseinzadeh Z, Bhavsar SK, Sopjani M et al (2011b) Regulation of the glutamate transporters by JAK2. Cell Physiol Biochem 28:693-702
17. Hosseinzadeh Z, Bhavsar SK, Lang F (2012a) Downregulation of ClC-2 by JAK2. Cell Physiol Biochem 29:737-742
18. Hosseinzadeh Z, Shojaiefard M, Bhavsar SK et al (2012b) Up-regulation of the betaine/GABA transporter BGT1 by JAK2. Biochem Biophys Res Commun 420:172-177
19. Hougaard C, Klaerke DA, Hoffmann EK et al (2004) Modulation of KCNQ4 channel activity by changes in cell volume. Biochim Biophys Acta 1660:1-6
20. Hunziker W, Whitney JA, Mellman I (1992) Brefeldin A and the endocytic pathway. Possible implications for membrane traffic and sorting. FEBS Lett 307:93-96
21. + channel in murine gastrointestinal smooth muscles. Am J Physiol Gastrointest Liver Physiol 297:G107-G115
22. Jepps TA, Chadha PS, Davis AJ et al (2011) Downregulation of Kv7.4 channel activity in primary and secondary hypertension. Circulation 124:602-611
23. Joshi S, Sedivy V, Hodyc D et al (2009) KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle. J Pharmacol Exp Ther 329:368-376
24. Lang F, Busch GL, Ritter M et al (1998) Functional significance of cell volume regulatory mechanisms. Physiol Rev 78:247-306
25. Lang F, Shumilina E, Ritter M et al (2006) Ion channels and cell volume in regulation of cell proliferation and apoptotic cell death. Contrib Nephrol 152:142-160
26. Lopez AF, Hercus TR, Ekert P et al (2010) Molecular basis of cytokine receptor activation. IUBMB Life 62:509-518
27. - conductances in rabbit proximal convoluted tubule. J Membr Biol 155:229-237
28. Mahfouz RA, Hoteit R, Salem Z et al (2011) JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in Lebanon. Genet Test Mol Biomarkers 15:263-265
29. Mistry HD, McCallum LA, Kurlak LO et al (2011) Novel expression and regulation of voltage-dependent potassium channels in placentas from women with preeclampsia. Hypertension 58:497-504
30. Morris DL, Rui L (2009) Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 297:E1247-E1259
31. Nie L (2008) KCNQ4 mutations associated with nonsyndromic progressive sensorineural hearing loss. Curr Opin Otolaryngol Head Neck Surg 16:441-444
32. Oh ST, Gotlib J (2010) JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms. Expert Rev Hematol 3:323-337
33. Pardanani A, Vannucchi AM, Passamonti F et al (2011) JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations. Leukemia 25:218-225
34. Rexhepaj R, Dermaku-Sopjani M, Gehring EM et al (2010) Stimulation of electrogenic glucose transport by glycogen synthase kinase 3. Cell Physiol Biochem 26:641-646
35. Santos FP, Verstovsek S (2011) JAK2 inhibitors: what's the true therapeutic potential? Blood Rev 25:53-63
36. Seebohm G, Strutz-Seebohm N, Baltaev R et al (2005) Regulation of KCNQ4 potassium channel prepulse dependence and current amplitude by SGK1 in Xenopus oocytes. Cell Physiol Biochem 16:255-262
37. Shojaiefard M, Hosseinzadeh Z, Bhavsar SK et al (2012) Downregulation of the creatine transporter SLC6A8 by JAK2. J Membr Biol 245:157-163
38. Sotty F, Damgaard T, Montezinho LP et al (2009) Antipsychotic-like effect of retigabine [N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission. J Pharmacol Exp Ther 328:951-962
39. Spivak JL (2010) Thrombocytosis, polycythemia vera, and JAK2 mutations: the phenotypic mimicry of chronic myeloproliferation. Ann Intern Med 152:300-306
40. + channel (ENaC) by ubiquitination. EMBO J 16:6325-6336
41. Strutz-Seebohm N, Seebohm G, Fedorenko O et al (2006) Functional coassembly of KCNQ4 with KCNE-beta-subunits in Xenopus oocytes. Cell Physiol Biochem 18:57-66
42. Strutz-Seebohm N, Pusch M, Wolf S et al (2011) Structural basis of slow activation gating in the cardiac I Ks channel complex. Cell Physiol Biochem 27:443-452
43. Tefferi A (2010) Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 24:1128-1138
44. Tefferi A, Skoda R, Vardiman JW (2009) Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol 6:627-637
45. Walter S, Atzmon G, Demerath EW et al (2011) A genome-wide association study of aging. Neurobiol Aging 32:2109-2128
46. Wang W, Gao XF, Xiao L et al (2011) K(V)7/KCNQ channels are functionally expressed in oligodendrocyte progenitor cells. PLoS One 6:e21792
47. Wei L, Xiao AY, Jin C et al (2004) Effects of chloride and potassium channel blockers on apoptotic cell shrinkage and apoptosis in cortical neurons. Pflugers Arch 448:325-334